Zoetis Inc. (ZTS) Analysts See $0.70 EPS; Staar Surgical Co (STAA) Has 1.79 Sentiment

April 25, 2018 - By Ellis Scott

Zoetis Inc. (NYSE:ZTS) Logo

Analysts expect Zoetis Inc. (NYSE:ZTS) to report $0.70 EPS on May, 2 before the open.They anticipate $0.17 EPS change or 32.08% from last quarter’s $0.53 EPS. ZTS’s profit would be $339.58M giving it 30.13 P/E if the $0.70 EPS is correct. After having $0.69 EPS previously, Zoetis Inc.’s analysts see 1.45% EPS growth. The stock decreased 1.11% or $0.95 during the last trading session, reaching $84.35. About 2.11 million shares traded. Zoetis Inc. (NYSE:ZTS) has risen 51.68% since April 25, 2017 and is uptrending. It has outperformed by 40.13% the S&P500.

Staar Surgical Co (STAA) investors sentiment decreased to 1.79 in Q4 2017. It’s down -0.07, from 1.86 in 2017Q3. The ratio has dropped, as 52 active investment managers increased or opened new holdings, while 29 reduced and sold stakes in Staar Surgical Co. The active investment managers in our database now own: 31.89 million shares, up from 31.59 million shares in 2017Q3. Also, the number of active investment managers holding Staar Surgical Co in top ten holdings was flat from 1 to 1 for the same number . Sold All: 6 Reduced: 23 Increased: 32 New Position: 20.

Analysts await STAAR Surgical Company (NASDAQ:STAA) to report earnings on May, 2. They expect $-0.01 earnings per share, up 80.00% or $0.04 from last year’s $-0.05 per share. After $0.02 actual earnings per share reported by STAAR Surgical Company for the previous quarter, Wall Street now forecasts -150.00% negative EPS growth.

Broadwood Capital Inc holds 23.45% of its portfolio in STAAR Surgical Company for 10.86 million shares. Palo Alto Investors Llc owns 3.50 million shares or 2.33% of their US portfolio. Moreover, Millrace Asset Group Inc. has 1.54% invested in the company for 103,571 shares. The Colorado-based Shine Investment Advisory Services Inc has invested 0.87% in the stock. Grandeur Peak Global Advisors Llc, a Us-based fund reported 327,766 shares.

The stock decreased 3.00% or $0.5 during the last trading session, reaching $16.15. About 110,980 shares traded or 0.34% up from the average. STAAR Surgical Company (STAA) has risen 52.85% since April 25, 2017 and is uptrending. It has outperformed by 41.30% the S&P500.

STAAR Surgical Company, together with its subsidiaries, designs, develops, makes, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company has market cap of $671.70 million. The firm provides Visian implantable collamer lenses to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It currently has negative earnings. It also offers minimally invasive intraocular lenses (IOLs), including foldable IOLs for use in minimally invasive cataract surgical procedures; aspheric IOLs that produce a clearer image than traditional spherical lenses; and nanoFLEX IOL, a single piece collamer aspheric optic, as well as preloaded injectors for use in cataract surgery.

Since January 1, 0001, it had 0 insider buys, and 5 sales for $216,553 activity.

Since February 21, 2018, it had 0 insider buys, and 4 sales for $6.83 million activity. Another trade for 32,000 shares valued at $2.60M was made by PECK KRISTIN C on Wednesday, February 21. On Friday, March 9 the insider Trawicki Roman sold $712,001. $2.89M worth of stock was sold by Lagano Roxanne on Wednesday, February 21. $625,414 worth of Zoetis Inc. (NYSE:ZTS) was sold by Chen Heidi C. on Friday, March 16.

Among 21 analysts covering Zoetis Inc (NYSE:ZTS), 14 have Buy rating, 0 Sell and 7 Hold. Therefore 67% are positive. Zoetis Inc had 79 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was maintained by Piper Jaffray on Friday, February 16 with “Buy”. Jefferies maintained the shares of ZTS in report on Tuesday, June 14 with “Buy” rating. On Wednesday, August 9 the stock rating was maintained by Craig Hallum with “Buy”. The company was maintained on Friday, August 25 by Piper Jaffray. The stock has “Buy” rating by Jefferies on Tuesday, January 16. The firm has “Market Perform” rating given on Tuesday, June 13 by BMO Capital Markets. Hilliard Lyons downgraded it to “Hold” rating and $9100 target in Thursday, April 19 report. The firm has “Overweight” rating given on Thursday, December 15 by Piper Jaffray. The company was maintained on Monday, August 7 by BMO Capital Markets. As per Tuesday, July 25, the company rating was maintained by Cantor Fitzgerald.

STAAR Surgical Company (NASDAQ:STAA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: